NPS MedicineWise has released through its Choosing Wisely Australia website guidance on pain management, based on work from the Faculty of Pain Medicine, the Australian & New Zealand College of Anaesthetists (ANZCA).
Among the recommendations are to avoid prescribing opioids, (particularly long-acting opioids) as first-line or monotherapy for chronic non-cancer pain, and not to prescribe them for any non-cancer pain without ongoing demonstration of functional benefit or periodic dose-reduction attempts.
Cautions are also issued around the use of neuropathy treatments pregablin and gabapentin as well as benzodiazapines.
Go to choosingwisely.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Feb 18
